# FDA Inspection 1166776 - LGM Pharma LLC - April 08, 2022

Source: https://www.keypedia.com/records/fda_inspections/lgm-pharma-llc/c2ba459e-719c-4b9c-84ed-25f4493fe073
Source feed: FDA_Inspections

> FDA Inspection 1166776 for LGM Pharma LLC on April 08, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166776
- Company Name: LGM Pharma LLC
- Inspection Date: 2022-04-08
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1312800 - 2026-03-12](https://www.keypedia.com/records/fda_inspections/lgm-pharma-llc/20cd3038-72f5-4e11-b8fc-440fb934a475)
- [FDA Inspection 1242488 - 2024-06-28](https://www.keypedia.com/records/fda_inspections/lgm-pharma-llc/387ff95a-5c74-4726-b1ff-966411874d97)
- [FDA Inspection 1166776 - 2022-04-08](https://www.keypedia.com/records/fda_inspections/lgm-pharma-llc/02bde5d0-dd40-4a85-b832-a86ce999f746)
- [FDA Inspection 1073414 - 2018-12-04](https://www.keypedia.com/records/fda_inspections/lgm-pharma-llc/6dbfe703-41e1-4652-8fbb-a378bed4c926)

Company: https://www.keypedia.com/companies/lgm-pharma-llc/45c8af36-9473-4ceb-8fd3-e3fd9c24582f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c